Safety Pharmacology
Fully compliant with FDA and SFDA GLP requirements
WuXi AppTec's Safety Pharmacology program in Suzhou brings together an experienced team of industry scientists to design and optimize a panel of both GLP and non-GLP safety assessment assays.
Combining our integrated in vitro and in vivo capabilities we offer a core battery of non-GLP cardiovascular screening assays using advanced instrumentation and industry leading techniques to rapidly identify and characterize potential safety risks.
Following industry best practices and meeting regulatory guidelines, our GLP cardiovascular, CNS and pulmonary models are meeting the validation milestones required by our industry partners and will be available on a broad scale in 2011.
Safety Pharmacology services include:
Non-GLP Cardiovascular Safety Screening Assays
- Guinea Pig QT Assay
- Rat Telemetry Studies
- SHR Studies for Cardiovascular Efficacy
- EKG and Indirect Blood Pressure in Dogs and Non-human Primates
- hERG assay
GLP CNS and Pulmonary Safety Pharmacology
- Rat FOB (Functional Observational Battery)
- Rat Pulmonary
GLP Cardiovascular and Pulmonary Safety Pharmacology
- Dog and Non-human Primates
- DSI JET® Telemetry Technology (conscious, unrestrained)
Click here for PDF with more information.